Streetbeat News

Analyst Ratings

PLTR

A significant investor has taken a bearish stance on Palantir Technologies (NYSE:PLTR), with 69% of recent trades being bearish and 30% bullish. The trades include 4 puts worth $406,866 and 9 calls worth $503,344. The targeted price range for Palantir over the last 3 months has been $10.0 to $20.0. The current price of PLTR is up 1.33% at $15.27, with the stock considered neutral between overbought and oversold.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 3:01 pm

VNRX

EF Hutton analyst Tim Moore has initiated coverage on VolitionRX (AMEX:VNRX) with a Buy rating and a price target of $4.5.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:58 pm

VRTS

Morgan Stanley analyst Michael Cyprys has maintained an Underweight rating on Virtus Inv (NASDAQ:VRTS) and raised the price target from $163 to $170.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:48 pm

ABBV

A significant bearish stance has been taken on AbbVie (NYSE:ABBV) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is split between 36% bullish and 63% bearish. The whales have been targeting a price range from $55.0 to $160.0 for AbbVie over the last 3 months. Barclays has upgraded its action to Overweight with a price target of $170, while Morgan Stanley maintains their Overweight rating with a price target of $196.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:46 pm

MRNA

A whale investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 70% of the spotted trades being bearish. The total amount for puts is $351,770 and for calls is $54,605. The whales have been targeting a price range from $60.0 to $110.0 for Moderna over the last 3 months. The price of MRNA is currently down -0.14% at $71.81, and RSI indicators suggest the stock may be oversold. Moderna's next earnings are expected to be released in 3 days.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:46 pm

TROW

Morgan Stanley analyst Michael Cyprys has maintained an Equal-Weight rating on T. Rowe Price Gr (NASDAQ:TROW) and lowered the price target from $109 to $101.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:46 pm

GDC

GOGO

GRVY

PLTK

SEAT

The article identifies five value stocks in the communication services sector, namely Vivid Seats (SEAT), Gogo (GOGO), GD Culture Group (GDC), GRAVITY Co (GRVY), and Playtika Holding (PLTK). These stocks are considered undervalued based on their low price-to-earnings (P/E) multiples. The article also provides recent earnings per share data for each company.

Portfolio Pulse from Benzinga Insights

October 30, 2023 | 2:44 pm

SLAB

Morgan Stanley analyst Craig Hettenbach has maintained an Equal-Weight rating on Silicon Laboratories (NASDAQ:SLAB) and lowered the price target from $154 to $110.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:44 pm

RCL

Morgan Stanley analyst Jamie Rollo has maintained an Equal-Weight rating on Royal Caribbean Gr (NYSE:RCL) and raised the price target from $95 to $100.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:41 pm

CTVA

BMO Capital analyst Joel Jackson has maintained an 'Outperform' rating on Corteva (NYSE:CTVA) but lowered the price target from $70 to $64.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2023 | 2:40 pm